-
-
-
-
-
-
-
Scholar Rock Provides Update on Timing of Committee for Medicinal Products for Human Use (CHMP) Opinion for Apitegromab Marketing Authorisation Application (MAA) for Spinal Muscular Atrophy (SMA)
-
-
-
-
-
-
-
Scholar Rock (SRRK) PT Lowered to $51 at Piper Sandler
-
-
-
-
-
-
-
Jefferies: 'We highlight multiple de-risked or commercial-stage names that we think have promising M&A potential'
-
-
-
-
15,768 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

